Raman Spectroscopic Analysis of Bronchoscopic Biopsy for Diagnosing Lung Cancer
NCT ID: NCT05799027
Last Updated: 2023-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2023-03-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The bronchoscopic biopsy sample of patients with visible lesions in the airway would undergo raman spectrum analysis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type
NCT06775002
SERS-Based Serum Molecular Spectral Detection of Invasive Lung Cancer
NCT06775015
Application of SERS Technology Based Intraoperative Navigation System in Lung Cancer
NCT05881057
Role of Bronchoscopy in Early Lung Cancer Screening of High Risk Population
NCT02277366
Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer
NCT02941003
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Raman spectrum analysis
The bronchoscopic biopsy sample of patients with visible lesions in the airway would undergo raman spectrum analysis.
Raman spectrum
The bronchoscopic biopsy sample of patients with visible lesions in the airway would undergo raman spectrum analysis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Raman spectrum
The bronchoscopic biopsy sample of patients with visible lesions in the airway would undergo raman spectrum analysis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Visible intratracheal lesions under bronchoscope
* Non-visible lesions suspected of lung cancer
Exclusion Criteria
* The patient has no definite diagnosis
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China-Japan Friendship Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gang Hou
Principal Investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-NHLHCRF-LX-01-0201-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.